Study to evaluate SAF312 eye drops in the treatment of post-operative corneal induced chronic pain (CICP) following Photorefractive Keratectomy (PRK) or Laser-assisted in Situ Keratomileusis (LASIK) surgeries
Recruiting
99 years or below
All
150 participants needed
1 Location
Brief description of study
Many patients suffer from acute ocular pain due to different problems, however there is no available treatment for chronic eye pain (long lasting eye pain). Very often eye pain is reported after surgical procedures, like PRK and LASIK. Up to 60% of patients continue to have chronic pain beyond one month; and in some cases, the pain will continue for many years or even permanently. SAF312 is currently under evaluation for the treatment of corneal induced chronic pain (CICP).
Detailed description of study
Many patients suffer from acute ocular pain due to different problems, however there is no available treatment for chronic eye pain (long lasting eye pain). Very often eye pain is reported after surgical procedures, like PRK and LASIK. Up to 60% of patients continue to have chronic pain beyond one month; and in some cases, the pain will continue for many years or even permanently. SAF312 is currently under evaluation for the treatment of corneal induced chronic pain (CICP).
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Medical Research, Cornea, corneal induced chronic pain, CICP
-
Age: 99 years or below
-
Gender: All
Post-operative corneal induced chronic pain
Updated on
04 Aug 2024.
Study ID: 849031
Find a site
,
Your Information has been sent successfully.
Send a message
Enter your contact details to connect with study team
Primary Contact
